Clinical and laboratory applied regulatory science
Ended Awarded Last action
- Contract number
- 75F40119F19001
- Awardee
-
Spaulding Clinical Research, LLC UEI HERBKHMPKQN5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,561,387
Award facts
- Opportunity
-
- Clinical and Laboratory Applied Regulatory Science Solicitation · FDARFP191208111 · Posted Jun 17, 2019
- Contract value 100% obligated
- $6,561,386.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $971,988 | |
| Original award | $5,589,399 |
About this award
This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical pharmacology studies, QT prolongation and electrocardiogram studies for cardiac safety evaluation, and providing regulatory process expertise. This delivery order is part of a $30 million single award Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Spaulding Clinical Research in 2019 to provide these services to the FDA through September 2024. The contract does not utilize a set-aside designation.
Quick answers
Who was awarded contract 75F40119F19001?
75F40119F19001 was awarded to Spaulding Clinical Research, LLC by Food and Drug Administration (Department of Health and Human Services) on September 23, 2019.
How much is contract 75F40119F19001 worth?
The government has obligated $6,561,387 on 75F40119F19001.
Is contract 75F40119F19001 an order under another contract?
Yes. 75F40119F19001 is a delivery order under 75F40119D10032, an indefinite delivery contract.
Was contract 75F40119F19001 competed?
The extent of competition for 75F40119F19001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award